Pathogenesis of acute myeloid leukaemia and inv(16)(p13;q22): a paradigm for understanding leukaemogenesis?
about
The epigenetic landscape of acute myeloid leukemiaClass III Receptor Tyrosine Kinases in Acute Leukemia - Biological Functions and Modern Laboratory AnalysisClinical outcome of de novo acute myeloid leukaemia patients with normal cytogenetics is affected by molecular genetic alterations: a concise reviewHematopoietic stem cells and retroviral infection.NrasG12D oncoprotein inhibits apoptosis of preleukemic cells expressing Cbfβ-SMMHC via activation of MEK/ERK axis.Patients with acute myeloid leukemia and RAS mutations benefit most from postremission high-dose cytarabine: a Cancer and Leukemia Group B studyFLT3-ITD cooperates with inv(16) to promote progression to acute myeloid leukemia.Eosinophilia: secondary, clonal and idiopathic.Supraphysiologic levels of the AML1-ETO isoform AE9a are essential for transformation.Multi-stage Friend murine erythroleukemia: molecular insights into oncogenic cooperation.Current findings for recurring mutations in acute myeloid leukemiaReview of current classification, molecular alterations, and tyrosine kinase inhibitor therapies in myeloproliferative disorders with hypereosinophilia.Human CD34+ cells expressing the inv(16) fusion protein exhibit a myelomonocytic phenotype with greatly enhanced proliferative ability.Secondary Adult Acute Myeloid Leukemia: a Review of Our Evolving Understanding of a Complex Disease Process.Molecular and cytogenetic abnormalities in acute myeloid leukemia: review and case studies.Transcriptional dysregulation mediated by RUNX1-RUNX1T1 in normal human progenitor cells and in acute myeloid leukaemia.The prevalence and clinical profiles of FLT3-ITD, FLT3-TKD, NPM1, C-KIT, DNMT3A, and CEBPA mutations in a cohort of patients with de novo acute myeloid leukemia from southwest China.Detection of N-RAS and K-RAS in their active GTP-bound form in acute myeloid leukemia without activating RAS mutations.[Acute myelomonocytic leukemia eosinophilic revealed by acute pancreatitis].Imatinib mesylate for refractory acute myeloblastic leukemia harboring inv(16) and a C-KIT exon 8 mutation.Molecular analysis of PDGFRalpha/beta genes in core binding factor leukemia with eosinophilia.Application of peripherally inserted central catheter in acute myeloid leukaemia patients undergoing induction chemotherapy.Acute myeloid leukemia with inv(16)(p13.1q22), abnormal eosinophils, and absence of peripheral blood and bone marrow blasts.The expression analysis of LATS2 gene in de novo AML patients.Promoter hypermethylation of the retinoic acid receptor beta2 gene is frequent in acute myeloid leukaemia and associated with the presence of CBFbeta-MYH11 fusion transcripts.Molecular typing of adult acute myeloid leukaemia: significance of translocations, tandem duplications, methylation, and selective gene expression profiling.Mutation analysis ofMYH11in acute myeloid leukemiaAcute Myeloid Leukemia
P2860
Q21284742-9E722059-BDFF-437C-A1EA-4CD687F8A276Q26797245-8EFDD61D-0FE7-4B05-B97F-2263E4038C76Q28301344-7EF87939-F0F0-4317-8437-A58E9C97AB86Q33677922-9669F8BA-2C38-4FD0-975B-7782BAFB2647Q33917204-6579A6B6-EDB9-4F09-B45E-1AB4BC33F26BQ34593276-A6AA7A83-2E87-4536-8088-9D98C37D2AA9Q36407239-8CD4B97C-6450-41BE-827B-9866AF88C749Q36471689-7AA5D5EC-77F6-4068-A457-C0CA83EBDE8EQ37181755-0A3626E3-6A2D-4359-8985-4C90A9ABDE65Q37317203-4B360E18-47A3-4344-B0D2-922CE4145725Q37932085-D56CB1E3-75A3-4816-AC0C-D8E095F5858FQ38131481-7112FE93-C1FD-4B2E-A8E7-ADC32D302BA6Q38288838-1F43A324-A01C-468A-9B82-6C71AB932AAEQ38542828-F5E516FA-1F14-4093-9BC6-56491E05328DQ38694679-DC8F09B2-DF00-4DDD-899B-70EB6AAD3AE5Q40075629-61F6DB27-156D-4CAB-A027-9F2F68A20107Q40202671-DAF0CEF4-7DDF-4877-A9E4-6ACF6E4CD449Q40241216-BB18CB80-A793-40DB-854C-91D1D64242B8Q42638853-FFC34908-2C2E-4834-B353-49178BBCA4F3Q46622781-CDA300AD-050E-4FF6-8B3D-49D9FD1D2508Q46846861-73B2CEB3-5A41-43DF-A65D-1B025878EDC1Q48004663-DD13E898-4EDF-4E02-840A-A3581A6EFE5FQ53224430-A8CFB6F3-5B97-4704-A407-2FD2A55338D9Q54212646-37CE8A60-FF7F-4170-9FB0-D06924901CD5Q54605238-0DC972BD-D7DF-40F5-977A-1247A6354DB4Q54631835-A543CE27-A63F-45FD-B4F7-A393AF04D224Q57567540-A2FA327F-04DC-4E8C-A25E-53382EE97BD5Q58481811-77E39CC6-6E23-4677-BB74-4E7C62C0CF47
P2860
Pathogenesis of acute myeloid leukaemia and inv(16)(p13;q22): a paradigm for understanding leukaemogenesis?
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Pathogenesis of acute myeloid leukaemia and inv
@nl
Pathogenesis of acute myeloid ...... understanding leukaemogenesis?
@ast
Pathogenesis of acute myeloid ...... understanding leukaemogenesis?
@en
type
label
Pathogenesis of acute myeloid leukaemia and inv
@nl
Pathogenesis of acute myeloid ...... understanding leukaemogenesis?
@ast
Pathogenesis of acute myeloid ...... understanding leukaemogenesis?
@en
prefLabel
Pathogenesis of acute myeloid leukaemia and inv
@nl
Pathogenesis of acute myeloid ...... understanding leukaemogenesis?
@ast
Pathogenesis of acute myeloid ...... understanding leukaemogenesis?
@en
P2860
P1476
Pathogenesis of acute myeloid ...... understanding leukaemogenesis?
@en
P2093
John T Reilly
P2860
P356
10.1111/J.1365-2141.2004.05236.X
P407
P577
2005-01-01T00:00:00Z